Syncing The Unsyncable: Legal and Policy Implications of Paperless Clinical Trials

by KIMBERLY RHODES* & MICHAEL ROMEO

With technology permeating so many facets of other industries, why has the medical and pharmaceutical industry lagged in matching the pace of technological advancement? Specifically, what are the legal and policy risks associated with hastening the clinical trial process by utilizing technology based clinical trial platforms versus traditional paper-based methods? That is the question this article seeks to answer.

View Full Article in PDF.

Leave a Reply